Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Endovia Health Sciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 23 | 24 | +1 |
| Shares | 2.07M | 2.28M | +213.1K (+10.3%) |
| Value | $2.83M | $2.19M | −$643.5K (−22.7%) |
New holders (5)
Institutions that held Endovia Health Sciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 79,573 | $76.5K | 0.00% |
| Millennium Management LLC | 15,533 | $15.0K | 0.00% |
| StoneX Group Inc. | 14,300 | $13.7K | 0.00% |
| Cutler Group LP | 10,360 | $9.00K | 0.00% |
| Bank of America Corp | 37 | $36 | 0.00% |
Sold out (4)
Institutions that held Endovia Health Sciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Verition Fund Management LLC | 30,044 | $41.0K |
| Marshall Wace, LLP | 15,343 | $21.0K |
| Royal Bank of Canada | 128 | $0 |
| Gradient Investments LLC | 100 | $0 |